```html

Erosive Esophagitis – A Comprehensive Medical Guide

Overview

Erosive esophagitis is a form of inflammation of the esophagus in which the lining (mucosa) becomes damaged enough to create visible erosions or ulcerations. It is the most severe end of the spectrum of gastro‑esophageal reflux disease (GERD). While occasional mild irritation is common, erosive changes signify that stomach acid (and sometimes bile) has repeatedly injured the esophageal tissue.

Who it affects: Adults of any age can develop erosive esophagitis, but prevalence increases after the age of 40. Women appear slightly more likely to develop erosive lesions, possibly because they report GERD symptoms more often.

Prevalence: Population‑based studies estimate that 5–10 % of adults in the United States have endoscopically confirmed erosive esophagitis, with higher rates (up to 20 %) in patients with chronic GERD symptoms. Worldwide, the prevalence mirrors the rising rates of obesity and dietary westernization (Mayo Clinic, 2023; WHO, 2022).

Symptoms

Symptoms can range from mild to severe, and many patients experience a combination of the following:

• Heartburn – a burning sensation behind the breastbone, especially after meals or when lying down.
• Regurgitation – sour or bitter liquid that rises into the throat or mouth.
• Odynophagia – pain while swallowing, often described as “sore throat” or “scratchy” feeling.
• Dysphagia – difficulty or sensation of food getting “stuck,” indicating more extensive erosions.
• Chest pain – may mimic angina; typically non‑cardiac in origin and worsens with food intake.
• Chronic cough, hoarseness, or throat clearing – irritation of the larynx from refluxed acid.
• Sore throat or globus sensation – feeling of a lump in the throat.
• Upper abdominal discomfort – bloating or a sense of fullness after meals.
• Unexplained weight loss – may result from avoidance of food due to pain.
• Nighttime symptoms – awakening with throat pain or cough.

When erosions become deep, patients may notice (hematemesis) vomiting of blood or (melena) black, tarry stools, both of which require urgent evaluation.

Causes and Risk Factors

Primary cause

The fundamental mechanism is chronic exposure of the esophageal mucosa to gastric contents—primarily hydrochloric acid, but also pepsin and bile—leading to chemical injury.

Contributing factors

• Lower esophageal sphincter (LES) dysfunction – transient relaxations or a permanently weak LES allow reflux.
• Hiatal hernia – an anatomical alteration that impairs LES pressure.
• Obesity – intra‑abdominal pressure increases reflux frequency (CDC, 2022).
• Pregnancy – hormonal relaxation of LES and increased abdominal pressure.
• Medications – NSAIDs, aspirin, bisphosphonates, potassium chloride, certain antibiotics, and some asthma inhalers can irritate the mucosa.
• Lifestyle – smoking, excessive alcohol, caffeine, carbonated beverages, and large fatty meals.
• Connective‑tissue disorders – scleroderma and systemic lupus can affect esophageal motility.
• Genetics – family history of GERD increases risk.

Diagnosis

Diagnosis combines a careful history, physical examination, and targeted investigations.

Initial evaluation

• Symptom questionnaire – frequency, severity, and triggers of heartburn/reflux.
• Physical exam – usually normal; may reveal epigastric tenderness.

Diagnostic tests

1. Upper endoscopy (esophagogastroduodenoscopy, EGD) – gold standard. A flexible camera visualizes erosions, grades severity (Los Angeles Classification A–D), and allows biopsies to rule out infection or eosinophilic esophagitis.
2. pH‑impedance monitoring – measures acid exposure over 24 hours, useful when symptoms are atypical or when endoscopy is normal.
3. Esophageal manometry – assesses LES pressure and motility, especially before anti‑reflux surgery.
4. Radiographic swallow (barium study) – rarely needed but can detect strictures or motility problems.
5. Laboratory tests – CBC, iron studies, and vitamin B12 if malabsorption is suspected; not diagnostic for erosive esophagitis itself.

Treatment Options

Treatment is aimed at reducing acid exposure, healing mucosal injury, and preventing recurrence.

Medications

• Proton pump inhibitors (PPIs) – omeprazole, esomeprazole, pantoprazole, lansoprazole. Standard initial dose 20–40 mg daily for 8–12 weeks; most effective for healing erosions (Cleveland Clinic, 2023).
• H2‑receptor antagonists – ranitidine (withdrawn in many markets), famotidine, cimetidine. Useful as adjuncts or for nighttime control.
• Antacids – calcium carbonate, magnesium hydroxide for immediate symptom relief; do not heal erosions.
• Prokinetics – domperidone, metoclopramide; help improve LES tone and gastric emptying, used when motility disorder coexists.
• Alginate‑based formulations – form a foam barrier (e.g., Gaviscon); may reduce reflux episodes.

Endoscopic and Surgical Procedures

• Endoscopic dilation – reserved for strictures that develop from chronic inflammation.
• Radiofrequency ablation (Stretta) or endoscopic mucosal resection – experimental for refractory cases.
• Fundoplication (laparoscopic Nissen or Toupet) – surgical tightening of the LES; considered when medical therapy fails or patient prefers a drug‑free approach.

Lifestyle and Dietary Modifications

• Elevate the head of the bed 10–15 cm.
• Avoid meals within 2–3 hours of lying down.
• Limit trigger foods: fatty/fried foods, chocolate, mint, citrus, tomato‑based sauces, spicy foods, caffeine, and alcohol.
• Adopt a weight‑loss program if BMI ≥ 30 kg/m² (lose 5–10 % of body weight can reduce reflux episodes by ~40 %).
• Quit smoking – nicotine reduces LES pressure.
• Wear loose‑fitting clothing to decrease abdominal pressure.

Living with Erosive Esophagitis

Effective self‑management can minimize flare‑ups and improve quality of life.

Daily habits

• Take PPIs as directed—usually 30 minutes before breakfast for optimal effect.
• Keep a symptom diary to identify personal trigger foods.
• Chew gum after meals (sugar‑free) to stimulate saliva, which neutralizes acid.
• Stay hydrated; sip water throughout the day but avoid large volumes at once.
• Practice mindful eating—small portions, thorough chewing, and slow pace.

Monitoring

Schedule follow‑up endoscopy 8–12 weeks after initiating therapy if you had Grade C/D erosions, or sooner if symptoms persist. Ongoing surveillance is recommended for patients with Barrett’s esophagus, a complication of chronic erosive esophagitis.

Psychological support

Chronic reflux can affect mood and sleep. Cognitive‑behavioral therapy (CBT) and stress‑reduction techniques (e.g., yoga, meditation) have shown modest benefits in reducing symptom perception (NIH, 2021).

Prevention

Preventive strategies focus on minimizing reflux episodes.

• Maintain a healthy weight – every 5 % weight loss reduces GERD symptoms by 25–30 % (Mayo Clinic, 2023).
• Adopt a Mediterranean‑style diet – high in fruits, vegetables, whole grains, and healthy fats; linked to lower GERD prevalence.
• Limit or avoid alcohol and tobacco.
• Wear loose clothing and avoid tight belts.
• Consider early treatment of hiatal hernia if diagnosed.

Complications

If erosive esophagitis remains untreated, the following serious complications can develop:

• Stricture formation – scar tissue narrows the esophagus, causing dysphagia.
• Barrett’s esophagus – metaplastic change of the lining; increases the risk of esophageal adenocarcinoma (approx. 0.5 % per year of progression).
• Esophageal ulceration or perforation – rare but life‑threatening.
• Chronic cough, asthma exacerbation, or laryngitis due to ongoing micro‑aspiration.
• Nutrient malabsorption – especially iron, calcium, and vitamin B12, leading to anemia or osteoporosis.

When to Seek Emergency Care

References

• Mayo Clinic. “Erosive Esophagitis.” Updated 2023. https://www.mayoclinic.org
• Cleveland Clinic. “Gastroesophageal Reflux Disease (GERD).” 2023. https://my.clevelandclinic.org
• World Health Organization. “Obesity and Chronic Disease.” 2022. https://www.who.int
• Centers for Disease Control and Prevention. “GERD in the United States.” 2022. https://www.cdc.gov
• National Institutes of Health. “Barrett’s Esophagus and Cancer Risk.” 2021. https://www.nih.gov
• American College of Gastroenterology. “Guideline for the Diagnosis and Management of Erosive Esophagitis.” 2022.

```